mark rupp, he's the director infectious diseases at the university of nebraska medical center.f you would update us on how many patients you have there now. at one point you had 15, and i wanted to get a sense of how their recovery is going. >> we are doing well. we successfully discharged some of the patients from the quarantine unit. we have one of those patients in the bio containment unit that came from tour community related to travel. so we are starting to see some cases within the community related to travel and close contact with that patient. but our experience is mir yoorg what we have seen throughout the country. lou: with testing, there is confusion about how many tests have been put out and it's sort of inexplicable to me that there has been in some cases apparently hundreds of thousands of test kits sent out but without a way in which to report whether those test kits have been used and whether the results are positive or negative. >> first of all, we welcome the increased amount of resources coming to bear on this. the announcement of billions of dollars coming o

mark rupp is joining us, tell us how important and why so important that vaccine research found that virus is not mutating as quickly as feared. >> this is good news, it means that the targets for the vaccine are likely to be stable over time. viewers are familiar with the influenctheinfluenza vaccine the to change every year to target that. we hope this one vaccine would be stable over a long period that would do the trick. david: if we make a vaccine, it did now mutate, does the fact we made a vaccine make it easier to make another one devoted to the mutation? >> pro see presumably you woulde to tweak the targets as necessary to redirect the nuveenventhe newvaccine, this dp questions of efficacy and safety, we would rather make one vaccine. david: remdesivir, a drug that has a lot of hope for treating the virus. no longer called an orphan drug. which i guess means it is going to be easier to make and cheaper for the consumer. you have done a lot of work on this drug, tell us about the promise it holds. >> well we're pleased this we're conducting a multi-center randomize placebo con

mark rupp. he's the infectious diseases director at the university of nebraska medical center.n. and appreciate your time. let's start with, first, the prospects for the drug that you are testing and working on. >> well, first of all, we have a terrific team here and, actually, dr. andre khalil is spearheading those efforts here. we are in the first clinical trial here in the united states with a drug, and this medication is inhibiting the viral replication. we've had one patient who has successfully received a study drug and has improved and has been transferred out of our biocontainment unit and continues to do well. we've had four people actually in the last 48 hours get transferred out of the quarantine unit and on their way home. so we're very pleased with how things are going. lou: well, that's very encouraging. and your sense of the president, obviously, is leading the nation, directing as much as any president could the effort to come up with a antiviral drug, a vaccine as quickly as possible. is it your sense that -- what are the limits to actually accelerating those e

mark rupp. he's the infectious disease expert at the university of nebraska.n5 masks. i was surprised we would need to do that, and turn to the military as well. that we have not converted production to meet the demand for those essential masks for our healthcare providers. >> we welcome the help from federal sources and from our industrial partners, construction companies. there are clearly some specifics they need to get into. the n95 respirators have to be fitted to be effective and use new. our hospital like other places, we are getting towards a critical shortage and we are putting in place everything we can to stretch our supplies. we are starting to put in measures to reuse them. we are looking at ways to disinfect them so they are safe to be used again. we are doing everything we can to stretch the capacity of those devices. this does point to some weaknesses of our current be system. with the he a is of not having the -- with the emphasis, this is a weakness that's coming back to bite us. we cannot ship the supplies to other parts of the country like

mark rupp, from the national quarantine center in nebraska, on the very front lines, fighting this coronavirusll of that at the top of the hour. liz, good to see. >> lou, i have a quick questions. i've been all over the hillary clinton email server story. >> yep. liz: i think when hillary sat down she said i can't recall in 21 of the 25 answers to the "judicial watch" lawsuit. i don't know what we can expect from this. it is interesting she is now been deposed. >> this would perhaps be a little different questioning because the fbi, she apologized, they didn't include that in the 302s, record of interviews. by the way they gave six of her people immunity which is never done. so there are a lot of questions to be asked that have never been asked. i'm looking forward to "judicial watch" having the opportunity. liz: striking i remember. immunity in an fbi probe. great to see you. >> thanks, liz. liz: great to see you. just ahead europe's open borders policy now breaking down. it is happening now. violent border clashes erupting. why? turkey says to europe, we'll release millions of asylum-seekers

mark rupp among our guests here tomorrow.oming up next, just how much has the wuhan virus affected the lives of all americans? and when will we come back. -- will we come back to a new normal? we'll talk about that with among others, dr. nicole saphier. we're awaiting the daily briefing from president trump and the coronavirus task force, that is ahead in this hour, we'll be back with much more, please stay with us. ur hand! i can save you... lots of money with liberty mutual! we customize your car insurance so you only pay for what you need! only pay for what you need. ♪ liberty. liberty. liberty. liberty. ♪ there are times when our need to connect really matters. to keep customers and employees in the know. to keep business moving. comcast business is prepared for times like these. powered by the nation's largest gig-speed network. to help give you the speed, reliability, and security you need. tools to manage your business from any device, anywhere. and a team of experts - here for you 24/7. we've always believed in the po

mark rupp among our guests here tomorrow. coming up next, just how much has the wuhan virus affected the lives of all americans? and when will we come back. -- will we come back to a new normal? we'll talk about that with among others, dr. nicole saphier. we're awaiting the daily briefing from president trump and the coronavirus task force, that is ahead in this hour, we'll be back with much more, please stay with us. i like liberty mutual. they get that no two people are alike and customize your car insurance so you only pay for what you need. what do you think? i don't see it. only pay for what you need. ♪ liberty. liberty. liberty. liberty. ♪ from across the city to come to this fellowship distribution spot and get food that they can't afford. (sorrowful music) - [announcer] there is an emergency food crisis for elderly holocaust survivors in the former soviet union. - [yael] this is a crisis. these elderly holocaust survivors are struggling to survive. they're starving, have little money for food, electricity or medicine.

mark rupp. thank you for your time. >> my pleasure. >> you have a unique perspective here.r team are some of the relatively few doctors in the country right now who have treated coronavirus patients. you had 13 of the diamond princess passengers tested positive in your care. can you give people some window into what the treatments have been like? >> currently there is no approved vaccine or treatment for coronavirus and therefore it is really important that with these initial patients that we try to learn as much as we can from them. and so we're proud of the fact that we have a clinical trial up and running here testing an antiviral agent. it is being led by one of our faculty, dr. andre khalil. we're trying to find out if this medication works. >> any clue on that front? dr. anthony fauci of nih talked about the promises of these clinical trials on these treatments. any clue yet on how promising the treatment might be. it is months out before you have the results. >> this is a drug that was developed and tested initially against ebola. it was found to be safe, but not ve

mark rupp from the national quarantine center located in nebraska, the university of nebraska.fference between reality on the ground and some, some of the impressions being created from washington, d.c. we'll be taking that up with him congressman andy biggs joins us. the head of the freedom caucus. we'll be talking about fisa. we'll be talking about stimulus programs. and talking of course with former reagan white house political director ed rollins. former national deputy security advisor to president trump, kt mcfarland. that straight ahead. please join us at the top of the hour. you will love it. elizabeth: i will love it. sounds really interesting what you're taking on. fascinating stuff, always good to see you, lou dobbs. >> appreciate it. elizabeth: bring in california republican tom mcclintock. thanks for joining us tonight. >> always a pleasure. elizabeth: your, your state is sanctuary state. from former i.c.e. acting chief tom homan what he says about cities and states. he says let i.c.e. into jails. that is the best common sense way to protect and help immigrant comm

mark rupp where he has been overseeing coronavirus patient treatment and dana bash, our chief political correspondent. sanjay, let me just start with you here where caitlyn left off. dr. burke said anyone in new york should be self-quarantining for the next 14 days. her logic is she's saying 60% of the new cases in the united states are coming from the new york metro area so that's where you're seeing the growth. now they're seeing pickup in places where those people went to. we've got, what, one in three tests in the new york metro area coming back positive. does all of that add up to you to a 14-day quarantine making sense? >> no, it doesn't, erin. quite simply, i mean, first of all, it's not part of the cdc guidelines anymore, these 14-day quarantines. we heard about that some time ago, but the idea that they're being sort of implemented like this, it just doesn't make a lot of sense. you also have washington state, you have california. i get that there are more cases in new york but it is clear that there are more cases around the country where people can be exposed. i get the idea

mark rupp jones us. he's the infectious control chief at the university of nebraska medical center, and he has been overseeing treatment for coronavirus patients. sanjay, let me start with you. so these new guidelines which trump put forth from the cdc, they say gatherings of no more than 10 people. yesterday that was 50. we know yesterday you had states doing 100 and 250 and 1,000. it has dramatically come down and now down to ten. what does the fact this is changing so quickly say to you? >> well, it says two things. i think first of all these are somewhat arbitrary numbers, obviously. there's no magic number in terms of size of gathering. although one can argue there shouldn't be gatherings. social distance means social distance, and you know no gatherings probably is going to meet that requirement. i think what i get the sense of, erin, the strategy is not shock people too much, to introduce these things slowly so people aren't too shocked. and i think when you saw dr. fauci come back up to the lecte